Qi Liu
Chief Medical Officer, Oncology
Pharmaceuticals
ZAI Lab
China
Biography
Qi Liu, M.D., Ph.D. has been our chief medical officer, oncology since 2015. Prior to joining Zai Lab, Dr. Liu was the clinical head of the BioVenture group at AstraZeneca and the executive medical director of AstraZeneca Oncology, where she played an important role in establishing AstraZeneca’s biologics joint ventures and was responsible for its joint venture global clinical development programs and regulatory strategy and submissions. She also played a key role in the TKI development program. Prior to joining AstraZeneca, Dr. Liu was an assistant professor at the MD Anderson Cancer Center. Dr. Liu received a medical degree from Shanghai Medical University (currently known as Shanghai Medical College of Fudan University) and a Ph.D. in molecular genetics from the University of Georgia. She completed a post-doctoral fellowship at Memorial Sloan Kettering Cancer Center and a medical oncology and hematology fellowship at the MD Anderson Cancer Center with board certifications in internal medicine, medical oncology and hematology.
Research Interest
Business, Management, Finance, Pharmaceuticals, Pharmacology, Oncology, Toxicology
